Atlantica, Inc.
$1.00$0.00 (0.0%)
Atlantica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
OTC · MYRX · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Myrexis, Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Myrexis, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:44 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $0.00 |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.00$0.00 (0.0%)
Atlantica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
$0.00$0.00 (0.0%)
TransAKT Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.63% below the high.
$0.00$0.00 (0.0%)
China Health Management Corp.’s quoted price sits in the lower half of its reported 52-week range, 48.75% below the high.
$0.00$0.00 (0.0%)
C2E Energy, Inc.: Financial Services · Shell Companies.
$0.00$0.00 (0.0%)
All American Pet Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00$0.00 (0.0%)
One World Ventures, Inc.: Technology · Information Technology Services.
$0.00$0.00 (0.0%)
Jade Art Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.31% below the high.
$0.00+$0.00 (+12.5%)
Lotus Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 34.68% below the high.